{
    "2021-11-05": [
        [
            {
                "time": "2021-10-15",
                "original_text": "See Why Emergent BioSolutions Stock Plunged 37% On Friday?",
                "features": {
                    "keywords": [
                        "Emergent",
                        "BioSolutions",
                        "Stock",
                        "Plunged"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Emergent Tanks as U.S. Ends Contract, Vaccine Maker Cuts Outlook",
                "features": {
                    "keywords": [
                        "Emergent",
                        "Tanks",
                        "U.S.",
                        "Contract",
                        "Vaccine",
                        "Maker",
                        "Cuts",
                        "Outlook"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Emergent Biosolutions shares tumble on news it will lose COVID vaccine production contract with govt",
                "features": {
                    "keywords": [
                        "Emergent",
                        "Biosolutions",
                        "shares",
                        "tumble",
                        "COVID",
                        "vaccine",
                        "production",
                        "contract",
                        "govt"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Coronavirus tally: Global cases of COVID-19 top 248.7 million and U.S. cancels Emergent BioSolutions vaccine deal",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Global",
                        "cases",
                        "COVID-19",
                        "U.S.",
                        "cancels",
                        "Emergent",
                        "BioSolutions",
                        "vaccine",
                        "deal"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "U.S. cancels multimillion dollar deal with Emergent BioSolutions, which produced contaminated J&J vaccines: report",
                "features": {
                    "keywords": [
                        "U.S.",
                        "cancels",
                        "multimillion",
                        "dollar",
                        "deal",
                        "Emergent",
                        "BioSolutions",
                        "contaminated",
                        "J&J",
                        "vaccines"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Strong",
                        "Value",
                        "Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "FATE's Q3 Loss Narrower Than Expected, Pipeline in Focus",
                "features": {
                    "keywords": [
                        "FATE",
                        "Q3",
                        "Loss",
                        "Narrower",
                        "Expected",
                        "Pipeline",
                        "Focus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}